Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety and efficacy of omadacycline as compared to moxifloxacin in the treatment of adults with community-acquired bacterial pneumonia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Paratek Pharmaceuticals Inc
NCT06966284 · Bacteremia Caused by Gram-Negative Bacteria, Bacterial Pneumonia
NCT06804096 · Pneumonia, Community-Acquired, Bacterial Pneumonia
NCT07004049 · Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, and more
NCT06103500 · Sepsis, Bacterial Infections, and more
NCT06162286 · Community-acquired Bacterial Pneumonia
Site 514
Birmingham, Alabama
Site 501
Mobile, Alabama
Site 508
Laguna Hills, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions